A nanochannel platform detects Aβ monomers, suggesting advanced monitoring for Alzheimer's disease.
We developed a modification-free glass nanochannel for sensitive and selective detection of Aβ monomers, which operates through a dispersion-dominated recognition mechanism based on stimuli-responsive polymer-functionalized gold nanoparticles. This platform was...
No takes yet. Share an insight, caveat, or question.
Ji et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: